BCG-unresponsive NMIBC is defined by persistent or recurrent high-grade tumors or carcinoma in situ after adequate BCG therapy. This condition requires alternative therapeutic strategies or radical ...

“Prostate cancer patients with life expectancies of less than 5 or 10 years were being subjected to treatments that can take up to a decade to significantly improve their chances of surviving cancer, ...

Men with limited life expectancy and intermediate- to high-risk prostate cancer are often overtreated in the VA health system. Active surveillance is now the most common approach for low-risk prostate ...

In this video, Jason M. Hafron, MD, discusses the impact of PSMA-PET imaging on prostate cancer management. Hafron is the chief medical officer and medical director of clinical research of Michigan ...

Augmented reality is being used to enhance surgical training, offering immersive 3D simulations for residents. The study employs Apple Vision Pro to improve pre-operative and post-operative ...

Online physician reviews are challenging to improve, with negative reviews more easily obtained than positive ones due to specific code words. Wait times surprisingly have minimal impact on online ...

ADI-270 targets CD70-positive cancers and is in a phase 1/2 trial for relapsed/refractory ccRCC, with initial results expected in early 2025. The trial evaluates safety, tolerability, pharmacokinetics ...

Patients with elevated CTC count at baseline experienced poor complete response rates and worsened PFS and OS.

Dr. Dean Laganosky received the 2024 Trailblazer Award from LUGPA for significant contributions to urology within his first decade of practice. At 37, Dr. Laganosky has pioneered advanced urologic ...

PARP inhibitors are gaining importance in prostate cancer treatment, offering alternatives to androgen deprivation therapy. Treatment strategies from breast and pancreatic cancer are being adapted for ...

New robotic systems, like CMR and Medtronic's Hugo, are entering the market, increasing competition and innovation in robotic surgery. The da Vinci 5 robot offers incremental improvements, such as ...

Water vapor thermal therapy, initially used for BPH, is being adapted for prostate cancer treatment with directional and image-guided enhancements. The VAPOR 2 trial, FDA-approved, aims to demonstrate ...